Definition and epidemiology
Williams syndrome is a multisystem neurodevelopmental disorder caused by a hemizygous microdeletion of approximately 1.5-1.8 Mb on chromosome 7q11.23, encompassing 26-28 genes including the elastin gene (ELN). This contiguous gene deletion syndrome results in a distinctive phenotype affecting cardiovascular, neurodevelopmental, endocrine, and craniofacial systems.
The incidence is approximately 1 in 7,500 to 1 in 10,000 live births, affecting all ethnic groups and both sexes equally. Most cases arise as de novo deletions, though rare familial cases with autosomal dominant inheritance have been reported. The syndrome was first described independently by J.C.P. Williams and A.J. Beuren in the early 1960s.
Lifespan is generally near-normal with appropriate medical management, though cardiovascular complications remain the primary cause of morbidity and mortality. Early diagnosis and multidisciplinary care significantly improve outcomes and quality of life.
- Williams syndrome: chromosome 7q11.23 deletion including elastin gene (ELN)
- Classic triad: supravalvular aortic stenosis, intellectual disability, elfin facies
- Stellate iris pattern is characteristic ocular finding
- Cognitive profile: relatively strong verbal skills, severe visuospatial deficits
- Hypersociability with overly friendly, disinhibited behavior
- Infantile hypercalcemia in 15%; avoid excessive vitamin D
- Diagnosis confirmed by chromosomal microarray or FISH for 7q11.23 deletion
- Increased anesthesia risk; requires cardiology clearance before procedures
Etiology and risk factors
Williams syndrome results from a microdeletion at chromosome 7q11.23, typically occurring as a sporadic de novo mutation during meiosis. The deletion can be of maternal or paternal origin with equal frequency. The critical region contains multiple genes, with haploinsufficiency of specific genes responsible for different phenotypic features:
- ELN (elastin): Supravalvular aortic stenosis, vascular stenoses, connective tissue abnormalities
- LIMK1: Visuospatial construction deficits
- STX1A: Possible contribution to hypersociability
- GTF2I and GTF2IRD1: Craniofacial features and cognitive profile
The deletion typically occurs through non-allelic homologous recombination between flanking low-copy repeats, making the region prone to rearrangement. There are no known environmental risk factors. Advanced parental age is not consistently associated with increased risk.
In the rare instances of familial transmission (less than 5% of cases), inheritance follows an autosomal dominant pattern with 50% recurrence risk. Parental testing is recommended when Williams syndrome is diagnosed to distinguish de novo from inherited deletions, which affects genetic counseling and family planning.
Pathophysiology
The pathophysiology of Williams syndrome reflects haploinsufficiency of multiple contiguous genes, with different genes contributing to specific phenotypic features.
Cardiovascular pathophysiology
Haploinsufficiency of the elastin gene (ELN) is central to the cardiovascular manifestations. Elastin is a critical component of arterial walls, providing elasticity and structural integrity. Reduced elastin production leads to arterial stenoses through abnormal smooth muscle cell proliferation and disorganized vascular architecture. Supravalvular aortic stenosis (SVAS) occurs in approximately 75% of patients, resulting from thickening and narrowing above the aortic valve. Peripheral pulmonary artery stenosis, renal artery stenosis, and other arterial narrowings follow similar mechanisms. Progressive stenoses can develop over time, necessitating lifelong cardiovascular surveillance.
Neurodevelopmental pathophysiology
The unique cognitive profile—mild to moderate intellectual disability (IQ typically 50-70) with relative strength in verbal abilities and facial recognition but significant visuospatial construction deficits—reflects the combined effects of multiple gene deletions. LIMK1 deletion contributes to impaired visuospatial processing. The characteristic overly friendly, socially disinhibited personality (hypersociability) may involve dysregulation of oxytocin pathways and altered function of genes affecting social cognition. Anxiety disorders are common, possibly related to amygdala dysfunction.
Endocrine and metabolic pathophysiology
Infantile hypercalcemia, present in approximately 15% of affected infants, results from increased sensitivity to vitamin D and dysregulated calcium homeostasis. The exact mechanism remains incompletely understood but may involve altered expression of genes affecting vitamin D metabolism. Hypercalcemia typically resolves by age 2-4 years but can cause failure to thrive, irritability, and nephrocalcinosis during infancy.
Clinical features
Williams syndrome presents with a multisystem phenotype that evolves with age. Recognition of the characteristic clinical pattern is essential for diagnosis.
Craniofacial features
The distinctive facial appearance—often described as "elfin facies"—includes:
- Broad forehead
- Periorbital fullness
- Stellate (starburst) pattern of the iris
- Short nose with anteverted nares and flat nasal bridge
- Long philtrum
- Wide mouth with full lips
- Small, widely spaced teeth with malocclusion
- Mild micrognathia
These features become more apparent with age and may be subtle in infancy.
Cardiovascular manifestations
- Supravalvular aortic stenosis (SVAS): Most common (75%), ranges from mild to severe
- Peripheral pulmonary artery stenosis: Present in 40-60%
- Hypertension: Common even without renal artery stenosis
- Other arterial stenoses: Renal, coronary, cerebral arteries
- Aortic coarctation and valvular abnormalities: Less common
Neurodevelopmental and behavioral features
- Intellectual disability: Mild to moderate (IQ 40-80, mean ~60)
- Language: Relative strength; expressive language better than expected
- Visuospatial deficits: Severe impairment in drawing, puzzles, construction tasks
- Hypersociability: Overly friendly, lack of stranger anxiety, socially disinhibited
- Anxiety disorders: Present in 50-80%, including specific phobias and generalized anxiety
- Attention deficit hyperactivity disorder (ADHD): Common
- Hyperacusis: Sensitivity to sounds in ~90%
Other clinical features
- Growth: Prenatal and postnatal growth restriction, short stature
- Endocrine: Infantile hypercalcemia (15%), hypothyroidism, early puberty
- Gastrointestinal: Chronic constipation, diverticulosis in adults
- Genitourinary: Renal anomalies, bladder diverticula, enuresis
- Musculoskeletal: Joint laxity or contractures, kyphoscoliosis
- Connective tissue: Soft, lax skin; premature aging of skin; hernias
- Dental: Microdontia, enamel hypoplasia, malocclusion
Diagnosis
Diagnosis of Williams syndrome combines clinical recognition with molecular genetic confirmation.
Clinical diagnosis
Suspicion arises from the characteristic phenotype: distinctive facial features, cardiovascular abnormalities (especially SVAS), developmental delay with the typical cognitive profile, and friendly personality. Diagnosis may occur at any age but is often made in early childhood when developmental delays and cardiovascular findings prompt evaluation. Infantile hypercalcemia may be the presenting feature in young infants.
Genetic testing
Fluorescence in situ hybridization (FISH) using an elastin gene probe was historically the gold standard, detecting the 7q11.23 deletion in approximately 95% of clinically diagnosed cases. Chromosomal microarray analysis (CMA) is now preferred as the first-line diagnostic test, as it detects the deletion with higher sensitivity and defines deletion size. CMA can identify atypical deletions and has largely replaced FISH in clinical practice.
Multiplex ligation-dependent probe amplification (MLPA) is an alternative technique that can detect the deletion and define breakpoints. Karyotype analysis is normal in Williams syndrome since the deletion is submicroscopic.
Diagnostic workup upon confirmation
Once Williams syndrome is confirmed, comprehensive baseline evaluation includes:
- Cardiovascular assessment: Echocardiography, blood pressure measurement in all four limbs, ECG; cardiology referral
- Renal evaluation: Renal ultrasound, assessment of renal function
- Endocrine screening: Serum calcium (especially in infancy), thyroid function, vitamin D level
- Developmental assessment: Formal cognitive and language evaluation
- Ophthalmologic examination: Assessment for strabismus, refractive errors
- Audiology evaluation: Hearing assessment, evaluation of hyperacusis
Differential diagnosis considerations
Prenatal diagnosis is possible if there is a family history, but Williams syndrome is rarely suspected prenatally in sporadic cases. Newborn screening does not detect Williams syndrome.
Differential diagnosis
Several conditions share overlapping features with Williams syndrome and should be considered:
Noonan syndrome: Shares cardiovascular abnormalities (especially pulmonary stenosis), short stature, and developmental delay. Distinguished by different facial features (downslanting palpebral fissures, low-set posteriorly rotated ears), webbed neck, and mutations in RAS-MAPK pathway genes rather than 7q11.23 deletion. Intellectual disability is typically milder.
Supravalvular aortic stenosis (isolated): Can occur as an isolated finding or in an autosomal dominant form due to point mutations in the elastin gene (ELN), without the other features of Williams syndrome. Patients lack the characteristic facial features, cognitive profile, and hypersociability.
Idiopathic infantile hypercalcemia: Presents with hypercalcemia in infancy but lacks the cardiovascular, facial, and neurodevelopmental features of Williams syndrome. May be caused by mutations in CYP24A1 or SLC34A1.
Rubinstein-Taybi syndrome: Shares intellectual disability and distinctive facial features, but characterized by broad thumbs and big toes, grimacing smile, and different facial appearance. No cardiovascular predisposition to SVAS.
Fetal alcohol syndrome: Can present with intellectual disability, growth restriction, and some overlapping facial features, but history of maternal alcohol exposure, absence of cardiovascular features, and different pattern of cognitive deficits distinguish it.
Smith-Magenis syndrome: Shares intellectual disability and behavioral abnormalities but has deletion of chromosome 17p11.2, distinct facial features, and self-injurious behavior rather than hypersociability.
Velocardiofacial syndrome (22q11.2 deletion): Presents with cardiovascular defects, developmental delay, and distinctive facial features, but conotruncal heart defects (VSD, tetralogy of Fallot) rather than SVAS, and hypocalcemia rather than hypercalcemia.
Management
Management of Williams syndrome requires lifelong multidisciplinary care addressing cardiovascular, developmental, endocrine, and psychosocial needs. No cure exists; treatment is supportive and preventive.
Cardiovascular management
Surveillance and monitoring: Regular cardiology follow-up with echocardiography is essential, as stenoses can progress. Blood pressure should be monitored in all four limbs due to risk of renal artery stenosis and hypertension. Frequency of assessment depends on severity of cardiovascular involvement.
Medical therapy: Antihypertensive medications when indicated. Avoid stimulant medications for ADHD if significant cardiovascular disease is present, or use with careful monitoring.
Surgical intervention: Indicated for hemodynamically significant SVAS or other arterial stenoses. Surgical outcomes are generally good, though restenosis can occur. Balloon angioplasty may be considered for peripheral pulmonary artery stenosis.
Endocarditis prophylaxis: Not routinely recommended under current guidelines except for specific high-risk cardiac conditions or prior endocarditis.
Activity restrictions: Competitive sports and strenuous activity may be restricted depending on cardiovascular severity. Individualized recommendations from cardiology.
Developmental and educational support
Early intervention: Physical therapy, occupational therapy, and speech therapy from infancy optimize development. Focus on motor skills, visuospatial abilities, and adaptive functioning.
Educational planning: Individualized education programs (IEPs) address specific learning needs. Capitalize on relative strengths in verbal abilities while providing support for visuospatial and mathematical reasoning deficits.
Behavioral and psychiatric management: Treatment of anxiety disorders, ADHD, and other behavioral issues through behavioral therapy and medications when appropriate. Selective serotonin reuptake inhibitors (SSRIs) for anxiety disorders. Management of hyperacusis with audiology and desensitization techniques.
Endocrine and nutritional management
Hypercalcemia management in infancy: Low-calcium, low-vitamin D diet if hypercalcemia is present. Avoid excessive vitamin D supplementation. Monitor calcium levels regularly until levels normalize (typically by age 2-4 years).
Growth monitoring: Regular growth assessment; consider growth hormone therapy evaluation if severe short stature, though use remains controversial.
Thyroid monitoring: Screen for hypothyroidism and treat with levothyroxine if present.
Other management considerations
Gastrointestinal: Management of chronic constipation with dietary modifications, stool softeners, or laxatives. Adult surveillance for diverticulosis.
Renal: Monitor renal function and screen for structural abnormalities. Management of any identified renal pathology.
Anesthesia precautions: Increased risk during anesthesia and sedation due to cardiovascular abnormalities. Cardiology clearance and use of experienced anesthesiologists recommended.
Genetic counseling: For families regarding recurrence risk, prenatal testing options for future pregnancies, and implications for affected individuals' future reproductive planning.
Transition to adult care
Planned transition from pediatric to adult care with continued multidisciplinary follow-up. Most adults require ongoing support for independent living, vocational training, and supervised living arrangements.
Complications and prognosis
Cardiovascular complications
Cardiovascular disease remains the primary cause of morbidity and mortality. Progressive stenoses can develop or worsen over time, requiring surgical intervention. Sudden cardiac death can occur, particularly in the setting of severe SVAS or coronary artery stenosis, and has been reported with anesthesia. Hypertension is common and requires long-term management. Adults are at increased risk for premature coronary artery disease and stroke.
Neurodevelopmental and psychiatric complications
Anxiety disorders affect the majority of individuals and can significantly impair quality of life. Social vulnerability due to hypersociability and lack of stranger awareness increases risk of exploitation. Mental health conditions including depression and specific phobias are common in adolescence and adulthood. Progressive decline in cognitive function is not typical, but adaptive functioning challenges persist.
Gastrointestinal and genitourinary complications
Adults have increased risk of diverticulosis and diverticulitis, requiring surveillance and dietary management. Recurrent urinary tract infections are common. Bladder diverticula may predispose to chronic infection. Chronic constipation can be problematic throughout life.
Endocrine and metabolic complications
Diabetes mellitus and glucose intolerance develop in some adults. Hypothyroidism may develop over time. Early puberty occurs in some individuals. Osteopenia and osteoporosis have been reported, possibly related to altered calcium metabolism and physical activity limitations.
Musculoskeletal complications
Progressive joint contractures or joint laxity can develop. Kyphoscoliosis may worsen and require intervention. Premature aging of connective tissue affects skin and other organ systems.
Prognosis
With appropriate multidisciplinary care, life expectancy approaches normal, though cardiovascular complications remain the primary determinant of long-term survival. Most individuals require supervised living and vocational support in adulthood but can achieve semi-independent functioning with appropriate resources. Educational attainment varies but most require special education services. Social outcomes are generally positive given the characteristically friendly personality, though social vulnerability requires ongoing supervision and support. Quality of life can be good with comprehensive medical and psychosocial support. Genetic counseling for affected individuals regarding reproductive risks is important, as offspring have a 50% chance of inheriting the deletion if the individual with Williams syndrome reproduces.
WILLIAMS: Wide mouth, Intellectual disability, Loud (hyperacusis), Long philtrum, Infantile hypercalcemia, Aortic stenosis (supravalvular), Microdontia, Stellate iris
Practice questions
1. A 3-year-old boy is brought to the clinic for evaluation of developmental delay. His mother reports that he is very friendly with strangers and has an unusual fear of loud noises. Physical examination reveals a low nasal bridge, full lips, and a stellate pattern in his irises. Auscultation reveals a systolic ejection murmur heard best at the right upper sternal border. Echocardiography shows narrowing of the aorta just above the aortic valve. Which of the following genetic abnormalities is most likely present?
2. A 6-month-old infant is brought to the emergency department for irritability, vomiting, and poor feeding for the past week. The infant has been diagnosed with Williams syndrome. Laboratory studies show: Serum calcium 13.2 mg/dL (normal 8.5-10.5), serum phosphate 3.1 mg/dL, parathyroid hormone 15 pg/mL (normal 10-65). Which of the following is the most appropriate immediate management?
3. A 12-year-old girl with Williams syndrome requires dental extraction under general anesthesia. Her medical history includes supravalvular aortic stenosis that was surgically repaired at age 5. She has been doing well with no cardiac symptoms. Which of the following is the most important preoperative step?
Frequently asked questions
What causes Williams syndrome?
Williams syndrome is caused by a deletion of approximately 26-28 genes on chromosome 7q11.23, including the elastin gene (ELN). This deletion typically occurs as a spontaneous (de novo) event during formation of reproductive cells and is not inherited from parents in most cases. The deletion of the elastin gene is responsible for the cardiovascular features, particularly supravalvular aortic stenosis, while deletion of other genes in the region contributes to the intellectual disability, distinctive facial features, and behavioral characteristics. Fewer than 5% of cases are inherited from an affected parent in an autosomal dominant pattern.
What are the first symptoms of Williams syndrome?
Early symptoms of Williams syndrome often appear in infancy and may include poor feeding, failure to thrive, irritability, and vomiting due to infantile hypercalcemia (elevated blood calcium). Distinctive facial features such as a broad forehead, full cheeks, and wide mouth may be noted but are often subtle in newborns. Developmental delays, particularly in motor milestones, become more apparent in the first year of life. A heart murmur may be detected during routine examination, prompting echocardiography that reveals supravalvular aortic stenosis or other cardiovascular abnormalities. Some infants may not show obvious symptoms initially, and the diagnosis is made later in childhood when developmental delays and the characteristic facial appearance become more evident.
How is Williams syndrome diagnosed?
Williams syndrome is diagnosed through a combination of clinical recognition and genetic testing. Chromosomal microarray analysis (CMA) is the preferred first-line test, as it can detect the characteristic deletion of the 7q11.23 region on chromosome 7 with high sensitivity. Fluorescence in situ hybridization (FISH) using an elastin gene probe is an alternative method. Clinical suspicion arises from the distinctive constellation of features: characteristic facial appearance (elfin facies), supravalvular aortic stenosis or other cardiovascular abnormalities, intellectual disability with relative verbal strengths, and a hypersocial personality. Once the genetic diagnosis is confirmed, comprehensive evaluation includes echocardiography, renal ultrasound, calcium level measurement, developmental assessment, and other organ system screening.
Is Williams syndrome curable?
Williams syndrome is not curable, as it is a genetic condition caused by a permanent deletion of genes on chromosome 7. However, many of the medical problems associated with Williams syndrome can be effectively managed with appropriate multidisciplinary care. Cardiovascular abnormalities can be monitored and treated with medications or surgery when needed. Developmental interventions including physical, occupational, and speech therapy can optimize outcomes. Behavioral and psychiatric conditions respond to therapy and medications. With comprehensive management, individuals with Williams syndrome can have near-normal life expectancy and achieve a good quality of life, though most require ongoing support for learning, daily living activities, and supervised living arrangements in adulthood.
Williams syndrome vs Noonan syndrome — what is the difference?
Williams syndrome and Noonan syndrome are distinct genetic conditions that share some overlapping features but have important differences. Williams syndrome is caused by deletion of chromosome 7q11.23 and characteristically features supravalvular aortic stenosis, elfin facial features (broad forehead, full lips, stellate iris), hypersociability, and infantile hypercalcemia. Noonan syndrome results from mutations in genes of the RAS-MAPK pathway and typically presents with pulmonary stenosis (rather than aortic), distinctive facial features (downslanting eyes, low-set posteriorly rotated ears), webbed neck, short stature, and bleeding tendency. The intellectual disability in Noonan syndrome is generally milder, and the hypersocial personality characteristic of Williams syndrome is absent. Genetic testing readily distinguishes between these conditions.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: Q93.8
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.